AI
Tuesday, March 02, 2021 11:07:17 AM
Jack, it is very telling that on this website page below, UCLA lists the only 2 current immunotherapy treatment options available at UCLA to treat brain cancer (GBM) as: DCVax & PD-1 inhibitors. These are facts, not hearsay.
Especially, considering that the only current open clinical trial, that is currently recruiting at UCLA for recurrent Glioblastoma, is ATL-DC (DCVax) plus Pembrolizumab (Keytruda).
It is all so plain to see, unless you refuse to see it, as some Bears on this board have chosen not to see this. You may not like these facts, but these are still facts.
https://www.uclahealth.org/braintumor/biologics
Especially, considering that the only current open clinical trial, that is currently recruiting at UCLA for recurrent Glioblastoma, is ATL-DC (DCVax) plus Pembrolizumab (Keytruda).
It is all so plain to see, unless you refuse to see it, as some Bears on this board have chosen not to see this. You may not like these facts, but these are still facts.
https://www.uclahealth.org/braintumor/biologics
